Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
Clinical trial NCT05785715 · TERMINATED
Trial details
- NCT number
- NCT05785715
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-24
- Primary completion
- 2025-05-30
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.